13F HOLDINGS REPORT
venBio Partners LLC
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0000905148-23-000738
Total Value
$276.3M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ACELYRIN INC | 00445A100 | 3,857,230 | $80.6M | 29.18% |
| 2 | ALX ONCOLOGY HLDGS INC | ALXO | 9,699,925 | $72.8M | 26.36% |
| 3 | PHARVARIS N V | PHVS | 4,264,672 | $64.6M | 23.37% |
| 4 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 1,035,396 | $36.4M | 13.19% |
| 5 | VENTYX BIOSCIENCES INC | 92332V107 | 424,032 | $13.9M | 5.03% |
| 6 | ELEVATION ONCOLOGY INC | 28623U101 | 2,914,255 | $4.4M | 1.60% |
| 7 | IMPEL PHARMACEUTICALS INC | 45258K109 | 2,759,791 | $3.5M | 1.27% |